M G Mott. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AnimalsAntigens, NeoplasmAntineoplastic Agents/therapeutic useB-Lymphocytes/drug effectsCell SurvivalChildCyclophosphamide/pharmacologyCytarabine/pharmacologyDisease Models, AnimalGraft RejectionGraft vs Host ReactionHumansImmunityImmunity, CellularImmunosuppressionImmunosuppressive Agents/therapeutic useKineticsLymph Nodes/drug effectsNeoplasms/drug therapyNeoplasms/immunologyNeoplasms/therapySpleen/drug effectsT-LymphocytesTransplantation Immunology
Substances： See more » Antigens, NeoplasmAntineoplastic AgentsImmunosuppressive AgentsCytarabineCyclophosphamide
Year: 1973 PMID： 4122012 DOI： 10.1016/s0140-6736(73)90399-1
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321